BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia
Given their recognized ability to kill acute myeloid leukemia (AML) blasts both <i>in vitro</i> and <i>in vivo</i>, Vγ9Vδ2 T cells are of growing interest in the design of new s...